BATM Advanced CommunicationsBVCLF 40 EBITDA Margin % is 24.09% as of Dec. 2025, which is 208% above its 10-year median of 7.83. GuruFocus rates BVCLF with a GF Score™ of 40/100. The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, BATM Advanced Communications ranks better than 66.54% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
BATM Advanced Communications EBITDA Margin % Related Terms
BATM Advanced Communications EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BVCLF vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BATM Advanced Communications EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where BATM Advanced Communications's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BATM Advanced Communications (BVCLF) has a EBITDA Margin % of 24.09% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BATM Advanced Communications and its competitors. This is 208% above median its historical median of 7.83. Over the past decade, BATM Advanced Communications' EBITDA Margin % has ranged from 0.83 to 22.18. According to the industry distribution chart, BATM Advanced Communications ranks #273 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 33.5%.
Is BATM Advanced Communications' EBITDA Margin % too high?
BATM Advanced Communications' current EBITDA Margin % of 24.09% is 208% above median its 10-year median of 7.83. Over the past 10 years, this metric has ranged from a low of 0.83 to a high of 22.18. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. BATM Advanced Communications' value of 24.09% is 222.3% above this industry median. Based on the distribution chart, BATM Advanced Communications ranks #273 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, BATM Advanced Communications has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does BATM Advanced Communications' EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BATM Advanced Communications ranks #273 out of 816 companies for EBITDA Margin %. This puts BATM Advanced Communications in the upper half of its industry. The industry median EBITDA Margin % is 7.48. BATM Advanced Communications' value of 24.09% is 222.3% above this benchmark. Historically, BATM Advanced Communications' own EBITDA Margin % has ranged from 0.83 to 22.18 over the past decade. While the company's 10-year median is 7.83 vs. the industry median of 7.48, BATM Advanced Communications has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BATM Advanced Communications's current EBITDA Margin % of 24.09% is 222.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BATM Advanced Communications and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BATM Advanced Communications's current EBITDA Margin % is 24.09%, which is 208% above median its own 10-year median of 7.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BATM Advanced Communications stock overvalued right now?
BATM Advanced Communications (BVCLF) has a current EBITDA Margin % of 24.09%. The current EBITDA Margin % is 24.09%, which is 208% above median its 10-year median of 7.83 and 222.3% above the Medical Devices & Instruments industry median of 7.48. BATM Advanced Communications' overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For BATM Advanced Communications (BVCLF), the current EBITDA Margin % is 24.09% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
40GF Score
Get the complete analysis for BVCLF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BVCLF has been successfully added to your 
